rs142006633

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001006630.2(CHRM2):​c.773A>G​(p.Asn258Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00125 in 1,613,034 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0014 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0012 ( 4 hom. )

Consequence

CHRM2
NM_001006630.2 missense

Scores

19

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 1.68
Variant links:
Genes affected
CHRM2 (HGNC:1951): (cholinergic receptor muscarinic 2) The muscarinic cholinergic receptors belong to a larger family of G protein-coupled receptors. The functional diversity of these receptors is defined by the binding of acetylcholine to these receptors and includes cellular responses such as adenylate cyclase inhibition, phosphoinositide degeneration, and potassium channel mediation. Muscarinic receptors influence many effects of acetylcholine in the central and peripheral nervous system. The muscarinic cholinergic receptor 2 is involved in mediation of bradycardia and a decrease in cardiac contractility. Multiple alternatively spliced transcript variants have been described for this gene. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0057683587).
BP6
Variant 7-137015638-A-G is Benign according to our data. Variant chr7-137015638-A-G is described in ClinVar as [Likely_benign]. Clinvar id is 227249.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population mid. gnomad4_exome allele frequency = 0.00124 (1807/1461054) while in subpopulation MID AF= 0.0191 (110/5762). AF 95% confidence interval is 0.0162. There are 4 homozygotes in gnomad4_exome. There are 939 alleles in male gnomad4_exome subpopulation. Median coverage is 31. This position pass quality control queck.
BS2
High Homozygotes in GnomAdExome4 at 4 gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CHRM2NM_001006630.2 linkc.773A>G p.Asn258Ser missense_variant Exon 4 of 4 ENST00000680005.1 NP_001006631.1 P08172A4D1Q0Q6SL56Q86SJ1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CHRM2ENST00000680005.1 linkc.773A>G p.Asn258Ser missense_variant Exon 4 of 4 NM_001006630.2 ENSP00000505686.1 P08172

Frequencies

GnomAD3 genomes
AF:
0.00138
AC:
210
AN:
151862
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000242
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00401
Gnomad ASJ
AF:
0.00490
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00104
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0348
Gnomad NFE
AF:
0.00149
Gnomad OTH
AF:
0.00239
GnomAD3 exomes
AF:
0.00145
AC:
362
AN:
249420
Hom.:
0
AF XY:
0.00151
AC XY:
203
AN XY:
134832
show subpopulations
Gnomad AFR exome
AF:
0.000185
Gnomad AMR exome
AF:
0.00186
Gnomad ASJ exome
AF:
0.00508
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000817
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00180
Gnomad OTH exome
AF:
0.00280
GnomAD4 exome
AF:
0.00124
AC:
1807
AN:
1461054
Hom.:
4
Cov.:
31
AF XY:
0.00129
AC XY:
939
AN XY:
726852
show subpopulations
Gnomad4 AFR exome
AF:
0.000688
Gnomad4 AMR exome
AF:
0.00238
Gnomad4 ASJ exome
AF:
0.00448
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000603
Gnomad4 FIN exome
AF:
0.0000562
Gnomad4 NFE exome
AF:
0.00113
Gnomad4 OTH exome
AF:
0.00232
GnomAD4 genome
AF:
0.00138
AC:
209
AN:
151980
Hom.:
1
Cov.:
32
AF XY:
0.00147
AC XY:
109
AN XY:
74298
show subpopulations
Gnomad4 AFR
AF:
0.000241
Gnomad4 AMR
AF:
0.00400
Gnomad4 ASJ
AF:
0.00490
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00104
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00149
Gnomad4 OTH
AF:
0.00237
Alfa
AF:
0.00231
Hom.:
0
Bravo
AF:
0.00151
TwinsUK
AF:
0.000539
AC:
2
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.00174
AC:
15
ExAC
AF:
0.00143
AC:
174
EpiCase
AF:
0.00338
EpiControl
AF:
0.00297

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Feb 13, 2018
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Jun 24, 2015
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

p.Asn258Ser in exon 5 of CHRM2: This variant is not expected to have clinical si gnificance because of its population frequency and lack of evolutionary conserva tion. It is present in 0.2% (135/66208) of European chromosomes screened by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs1420 06633). Two mammals and >10 bird, reptile and fish species carrying a serine (Se r) at position 258, supporting that this change may be tolerated. -

Dilated Cardiomyopathy, Dominant Benign:1
Jan 22, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

CHRM2-related disorder Benign:1
Apr 07, 2021
PreventionGenetics, part of Exact Sciences
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.058
BayesDel_addAF
Benign
-0.60
T
BayesDel_noAF
Benign
-0.64
CADD
Benign
13
DANN
Benign
0.76
DEOGEN2
Benign
0.043
T;T;T;T
Eigen
Benign
-0.52
Eigen_PC
Benign
-0.27
FATHMM_MKL
Benign
0.68
D
LIST_S2
Benign
0.80
.;.;.;T
M_CAP
Benign
0.0075
T
MetaRNN
Benign
0.0058
T;T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
-1.1
N;N;N;N
PrimateAI
Benign
0.39
T
PROVEAN
Benign
-0.090
N;N;N;N
REVEL
Benign
0.12
Sift
Benign
0.96
T;T;T;T
Sift4G
Benign
0.87
T;T;T;T
Polyphen
0.0
B;B;B;B
Vest4
0.016
MVP
0.68
MPC
0.44
ClinPred
0.0067
T
GERP RS
4.3
Varity_R
0.039
gMVP
0.15

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs142006633; hg19: chr7-136700385; COSMIC: COSV57769968; API